Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | ARGX | RVMD | ||
| Company | Alnylam Pharmaceuticals | Argenx Se ADR | Revolution Medicines Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 314.71 | 904.79 | 192.22 | ||
| High | 322.49 | 904.79 | 192.33 | ||
| Low | 293.78 | 868.54 | 184.79 | ||
| Latest | 298.76 | 877.62 | 186.88 | ||
| Change | -14.03 | -31.87 | -4.25 | ||
| % Change | -4.49% | -3.50% | -2.22% | ||
| Volume | 2,538,200 | 325,000 | 1,355,200 | ||
| 20-Day Average Volume | 1,544,140 | 384,000 | 3,206,290 | ||
| Previous Close | 312.79 | 909.49 | 191.13 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 296.73 | 896.96 | 175.54 | ||
| 20-Day Raw Stochastic | 24.00% | 34.43% | 86.21% | ||
| 20-Day Relative Strength | 49.14 | 51.19 | 65.78 | ||
| Weighted Alpha | -15.69 | +45.83 | +200.02 | ||
| Today's Opinion | 40% Sell | 72% Buy | 100% Buy | ||
| Previous Opinion | 40% Sell | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Sell | 56% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.48% since 07/02/26 | -6.60% since 07/02/26 | -1.25% since 07/02/26 | ||
| Low | 293.78 on 07/10/26 | 868.54 on 07/10/26 | 184.79 on 07/10/26 | ||
| High | 380.00 on 07/09/26 | 940.26 on 07/06/26 | 193.82 on 07/09/26 | ||
| 1-Month | |||||
| %Chg | +2.59% since 06/10/26 | +1.79% since 06/10/26 | +29.61% since 06/10/26 | ||
| Low | 273.11 on 06/18/26 | 837.74 on 06/24/26 | 143.47 on 06/11/26 | ||
| High | 380.00 on 07/09/26 | 953.58 on 07/02/26 | 193.82 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | -7.25% since 04/10/26 | +9.75% since 04/10/26 | +93.80% since 04/10/26 | ||
| Low | 273.11 on 06/18/26 | 754.84 on 04/29/26 | 127.00 on 04/13/26 | ||
| High | 380.00 on 07/09/26 | 953.58 on 07/02/26 | 193.82 on 07/09/26 | ||
| 6-Month | |||||
| %Chg | -24.99% since 01/09/26 | +11.30% since 01/09/26 | +57.52% since 01/09/26 | ||
| Low | 273.11 on 06/18/26 | 661.85 on 03/20/26 | 91.52 on 03/30/26 | ||
| High | 380.00 on 07/09/26 | 953.58 on 07/02/26 | 193.82 on 07/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 39,888,344 | 54,577,420 | 39,729,940 | ||
| Shares Outstanding, K | 133,513 | 62,188 | 212,596 | ||
| Annual Sales | 3,713,940,000 | 4,248,050,000 | 0 | ||
| Annual Net Income | 313,750,000 | 1,292,040,000 | -1,131,300,000 | ||
| Last Quarter Sales | 1,167,180,000 | 1,313,000,000 | 0 | ||
| Last Quarter Net Income | 205,990,000 | 366,000,000 | -453,820,000 | ||
| 60-Month Beta | 0.27 | 0.45 | 1.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.99 on 04/30/26 | 5.52 on 05/07/26 | -2.29 on 05/06/26 | ||
| Earnings Date | 07/30/26 | 07/30/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 85.70 | 40.49 | 0.00 | ||